Colla Carrie H, Goodney Philip P, Lewis Valerie A, Nallamothu Brahmajee K, Gottlieb Daniel J, Meara Ellen
From Dartmouth Institute for Health Policy and Clinical Practice, Hanover, NH (C.H.C., P.P.G., V.A.L., D.J.G., and E.M.); Section of Vascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH (P.P.G.); Center for Health Outcomes and Policy, University of Michigan, Ann Arbor, MI (B.K.N.); and National Bureau of Economic Research, Cambridge, MA (E.M.).
Circulation. 2014 Nov 25;130(22):1954-61. doi: 10.1161/CIRCULATIONAHA.114.011470. Epub 2014 Oct 20.
Accountable care organizations (ACOs) seek to reduce growth in healthcare spending while ensuring high-quality care. We hypothesized that accountable care organization implementation would selectively limit the use of discretionary cardiovascular care (defined as care occurring in the absence of indications such as myocardial infarction or stroke), while maintaining high-quality care, such as nondiscretionary cardiovascular imaging and procedures.
The intervention group was composed of fee-for-service Medicare patients (n=819 779) from 10 groups participating in a Medicare pilot accountable care organization, the Physician Group Practice Demonstration (PGPD). Matched controls were patients (n=934 621) from nonparticipating groups in the same regions. We compared use of cardiovascular care before (2002-2004) and after (2005-2009) PGPD implementation, studying both discretionary and nondiscretionary carotid and coronary imaging and procedures. Our main outcome measure was the difference in the proportion of patients treated with imaging and procedures among patients of PGPD practices compared with patients in control practices, before and after PGPD implementation (difference-in-difference). For discretionary imaging, the difference-in-difference between PGPD practices and controls was not statistically significant for discretionary carotid imaging (0.17%; 95% confidence interval, -0.51% to 0.85%; P=0.595) or discretionary coronary imaging (-0.19%; 95% confidence interval, -0.73% to 0.35%; P=0.468). Similarly, the difference-in-difference was also minimal for discretionary carotid revascularization (0.003%; 95% confidence interval, -0.008% to 0.002%; P=0.705) and coronary revascularization (-0.02%; 95% confidence interval, -0.11% to 0.07%; P=0.06). The difference-in-difference associated with PGPD implementation was also essentially 0 for nondiscretionary cardiovascular imaging or procedures.
Implementation of a pilot accountable care organization did not limit the use of discretionary or nondiscretionary cardiovascular care in 10 large health systems.
负责医疗组织(ACO)旨在降低医疗保健支出的增长,同时确保高质量的医疗服务。我们假设负责医疗组织的实施将有选择地限制酌情心血管护理(定义为在没有心肌梗死或中风等指征的情况下进行的护理)的使用,同时维持高质量的医疗服务,如非酌情心血管成像和手术。
干预组由来自参与医疗保险试点负责医疗组织(医生集团实践示范,PGPD)的10个组的按服务收费的医疗保险患者(n = 819779)组成。匹配的对照组是来自同一地区非参与组的患者(n = 934621)。我们比较了PGPD实施之前(2002 - 2004年)和之后(2005 - 2009年)心血管护理的使用情况,研究了酌情和非酌情的颈动脉和冠状动脉成像及手术。我们的主要结局指标是PGPD实践中的患者与对照实践中的患者在PGPD实施前后接受成像和手术治疗的患者比例差异(差异中的差异)。对于酌情成像,PGPD实践与对照组之间在酌情颈动脉成像(0.17%;95%置信区间,-0.51%至0.85%;P = 0.595)或酌情冠状动脉成像(-0.19%;95%置信区间,-0.73%至0.35%;P = 0.468)方面的差异中的差异无统计学意义。同样,酌情颈动脉血运重建(0.003%;95%置信区间,-0.008%至0.002%;P = 0.705)和冠状动脉血运重建(-0.02%;95%置信区间,-0.11%至0.07%;P = 0.06)的差异中的差异也很小。与PGPD实施相关的差异中的差异对于非酌情心血管成像或手术也基本为0。
在10个大型医疗系统中,试点负责医疗组织的实施并未限制酌情或非酌情心血管护理的使用。